Volume 28; Issue 3

Main
Clinical Therapeutics
Volume 28; Issue 3

Clinical Therapeutics

Volume 28; Issue 3

1

A 6-week, double-masked, paralle-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension

Wendy A. Franks, Jean P. Renard, Ian A. Cunliffe, Prin Rojanapongpun

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 881 KB

english, 2006

2

Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study

Fiona Dunbar, Young Zhu, H. Robert Brashear

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 874 KB

english, 2006

3

Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate

Michael A. Kaliner

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.56 MB

english, 2006

4

Metformin-associated lactic acidosis treated with continuous renal replacement therapy

Polichronis Alivanis, Ioannis Giannikouris, Christos Paliuras, Antonios Arvanitis, Maria Volanaki, Agelos Zervos

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 633 KB

english, 2006

5

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002

Kathleen M. Fox, Robert A. Gerber PharmD, Bjorn Bolinder, Jack Chen, Sanjaya Kumar

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 951 KB

english, 2006

6

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study

Thomas J. Spencer, Howard B. Abikoff, Daniel F. Connor, Joseph Biederman, Steven R. Pliszka, Samuel Boellner, Stephanie C. Read, Raymond Pratt

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.92 MB

english, 2006

7

A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years

Jay L. Goldstein, James Aisenberg, Frank Lanza, Howard Schwartz, George H. Sands, Manuela F. Berger, Sharon Pan

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.35 MB

english, 2006

8

A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee

Alan Kivitz, Carl Ma, Harry Ahdieh, Bradley S. Galer

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.46 MB

english, 2006

9

Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects

Linda E. Gustavson, Sarah M. Schweitzer, David A. Burt, Ramanuj Achari, Matthew J. Rieser, Timi Edeki, Titus Chira, H. Daniel Yannicelli, Maureen T. Kelly

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.55 MB

english, 2006

10

Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study

Jianguo Li, June Zhao, Jennifer E. Hamer-Maansson, Tommy Andersson, Rose Fulmer, Marta Illueca, Per Lundborg

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1006 KB

english, 2006

11

Reporting race and ethnicity in clinical studies and health services research

Stephen Joel Coons

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 219 KB

english, 2006

12

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Jarir Atthobari, Folkert W. Asselbergs, Cornelis Boersma, Robin de Vries, Hans L. Hillege, Wiek H. van Gilst, Ron T. Gansevoort, Paul E. de Jong, Lolkje T.W. de Jong-van den Berg, Maarten J. Postma

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.50 MB

english, 2006